Tepylute Injection
Product Images NDC 81927-105

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tepylute (NDC 81927-105). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Shorla Oncology Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

15 mg Vial Label (Image01)

Label for TEPYLUTE (thiotepa) injection, 15 mg per 1.5 mL vial (10 mg/mL), marketed by Shorla Oncology Inc. The single-dose vial label includes instructions for intravenous infusion, dilution prior to use, and storage requirements at 2°C to 8°C. The label warns that it is a hazardous drug and states it should not be frozen.*

FDA Label Image

15 mg Vial Carton (Image02)

Packaging label for Tepylute (thiotepa) injection 10 mg/mL, supplied as 15 mg/1.5 mL single-dose vial. The label indicates it is for intravenous infusion and must be diluted prior to use. It includes manufacturer Shorla Oncology Inc. and contains handling and storage instructions, warnings, and a barcode.*

FDA Label Image

Structure (Structure01)

Chemical structure of thiotepa showing a phosphorus atom bonded to sulfur and three aziridine rings, consistent with the active ingredient in TEPYLUTE 10 mg/mL injection by Shorla Oncology Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.